Zenith Capital Corp. Stock

Equities

ZHCLF

CA98935N1033

Market Closed - OTC Markets Other stock markets 01:33:54 2024-04-24 pm EDT			5-day change	1st Jan Change
0.2 ^USD	-13.04%		0.00%	+66.67%

Apr. 05	Zenith Capital Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024	CI
2023	Zenith Capital Corp. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2023	CI

Financials (USD)

Sales 2022	-	Sales 2023	-	Capitalization	17.24M
Net income 2022	-7M	Net income 2023	-13M	EV / Sales 2022	-
Net Debt 2022	3.47M	Net Debt 2023	4.4M	EV / Sales 2023	-
P/E ratio 2022	-3.05 x	P/E ratio 2023	-1.27 x	Employees	-
Yield 2022 *	-	Yield 2023	-	Free-Float	0%

More Fundamentals * Assessed data

Chart Zenith Capital Corp.

Duration

Period

Style

Dynamic Chart

Latest news about Zenith Capital Corp.

Zenith Capital Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024	Apr. 05	CI
Zenith Capital Corp. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2023	Dec. 22	CI
Zenith Capital Corp. Reports Earnings Results for the First Quarter Ended July 31, 2023	23-09-27	CI
Zenith Capital Corp. Reports Earnings Results for the Full Year Ended April 30, 2023	23-08-28	CI
Zenith's Bet Inhibitor ZEN-3694 Providing Significant Clinical Benefit in Patients with Aggressive Cancer Type	23-06-01	CI
Zenith Capital Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2023	23-04-06	CI
Zenith Capital Corp. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2022	22-12-23	CI
Zenith Capital Corp. Reports Earnings Results for the First Quarter Ended July 31, 2022	22-09-29	CI
Zenith Capital Corp. Auditor Raises 'Going Concern' Doubt	22-09-14	CI
Zenith Capital Corp. Reports Earnings Results for the Full Year Ended April 30, 2022	22-09-14	CI
Zenith Epigenetics Announces Initiation of Phase 2b Triple Negative Breast Cancer Clinical Trial	22-05-10	CI
Zenith Capital Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2022	22-03-31	CI
Zenith Epigenetics Provides Clinical Update	22-01-31	CI
Zenith Epigenetics Announces Changes to Board of Directors	22-01-31	CI
Zenith Capital Corp. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2021	21-12-20	CI

More news

Quotes and Performance

1 day	-13.04%
Current month	+33.33%
1 month	+33.33%
3 months	+81.82%
6 months	+66.67%
Current year	+66.67%

More quotes

Highs and lows

1 week

0.20

0.23

1 month

0.15

0.23

Current year

0.10

0.23

1 year

0.00

0.23

3 years

0.00

0.45

5 years

0.00

0.97

10 years

0.00

0.97

More quotes

Managers and Directors - Zenith Capital Corp.

Managers	Title	Age	Since
Donald McCaffrey CEO	Chief Executive Officer	-	13-04-09
Anthony Cann DFI	Director of Finance/CFO	76	13-03-31
Henrik Hansen COO	Chief Operating Officer	-	13-06-30

Members of the board	Title	Age	Since
Kenneth Zuerblis BRD	Director/Board Member	64	13-04-09
Donald McCaffrey CEO	Chief Executive Officer	-	13-04-09
Norman Wong BRD	Director/Board Member	-	15-11-25

More insiders

Quotes

Date	Price	Change	Volume
24-04-24	0.2	-13.04%	15,900
24-04-23	0.23	+15.00%	8,350

Delayed Quote OTC Markets, April 24, 2024 at 01:33 pm EDT

More quotes

Company Profile

Sector

Calendar

2024-08-26 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data